Akèy › Dematomiyozit › Maryland › Baltimore
Etid klinik pou Dematomiyozit nan Baltimore, MD
4 etid pou Dematomiyozit ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Ap rekriteFaz 3
- Research Site, Baltimore
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
- Johns Hopkins Hospital, Baltimore
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Ap rekriteFaz 1
- Johns Hopkins University, Baltimore
Etid Dematomiyozit nan lòt vil
- Durham, NC8 etid
- Washington, DC7 etid
- New York City, NY5 etid
- Pittsburgh, PA5 etid
- Houston, TX5 etid
- Boston, MA5 etid
- Philadelphia, PA4 etid
- Miami, FL4 etid
- Cleveland, OH3 etid
- Kansas City, KS3 etid
- Jacksonville, FL3 etid
- Aurora, CO3 etid
Lòt etid nan Baltimore
- Kansè Poumon ki pa ti selil60 etid
- Kansè nan tete47 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Kansè (tout kalite)37 etid
- Kansè kolorektal31 etid
- Kansè pankreyas31 etid
- Kansè Metastatik28 etid
- Obèsite25 etid
- Ensifizyans kadyak24 etid
- Kansè vejik24 etid
- Akidan serebavaskilè22 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.